EU project starts work on world's largest dyslexia databank

A new EU-funded project is aiming to create the world's largest databank on dyslexia. Dyslexia is a common learning disorder that affects at least 5% of school children in Europe. The range and severity of the problem varies widely, but the main areas of difficulty are reading, writing, spelling, numeracy, personal organisation and time-keeping. The degree to which individuals may be affected ranges from mild spelling difficulties to severe organisational problems or complete illiteracy.

"Dyslexia is a huge societal problem, affecting one out of five children in Europe," says Franck Ramus of the French National Centre for Scientific Research (CNRS). "Although not as widespread compared to other diseases, it presents a major handicap to those that suffer from it."

CNRS is one of 13 partnering organisations from nine European countries involved in NEURODYS, a project funded under the "Life sciences, genomics and biotechnology for health" section of the Sixth Framework Programme (FP6). The purpose is to determine the biological and environmental factors involved in the disease.

"There's been a lot of research on dyslexia over the last 30 years, mainly on a cognitive and brain basis," told Dr Ramus. Neurological research suggests dyslexia is caused by some abnormality in the function of the left side of the brain which controls the lexical system, whereas cognitive research in recent years has increasingly focused on problems of phonological awareness - the awareness of the speech sounds within words. This has led to some speculation that these problems may be associated with a specific area of the brain. However, much of the research has been inconclusive.

"The NEURODYS project will also study dyslexia from the cognitive and brain basis but the main emphasis will be on its genetic basis," said Dr Ramus. "Although there has been some preliminary work done on dyslexia in the field of genetics, it was only with the mapping of the human genome in 2003, that real molecular studies on dyslexia could start." Specifically, the project will explore the links between the underlying active brain regions and risk-conferring genes.

One of the challenges of conducting a pan-European genetics study on dyslexia is the exceptionally large dataset required. Over a three-year period, the project aims to collect samples from a total of 4,000 children, coming from different countries across Europe to allow researchers to take into account language and environmental specificities.

A total of 2,000 samples have been collected so far and work has begun to develop a database. "This will be the world's largest databank," said Dr Ramus, who expects to see it get even bigger in the months to come. "There is mounting interest by US research groups to merge with us and create a transatlantic project on dyslexia."

By integrating new data at the molecular, cerebral and behavioural levels from across the different countries, the project partners expect to gain a deeper insight into which aspects of dyslexia are universal, and which are specific to each language. It will also enable scientists to establish a solid basis for improving diagnosis and treatment.

For further information, please visit:

  • http://www.neurodys.com
  • http://cordis.europa.eu/lifescihealth/home.html

    Copyright ©European Communities, 2006
    Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...